Treatment of Prader-Willi syndrome

Details Treatment of Prader-Willi syndrome Treatment of Prader-Willi syndrome

1989-07-24

1991-04-09

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514177, 514909, A61K 3156

Patent

active

050065173

ABSTRACT:
Prader-Willi Syndrome is alleviated by administering of a 3-oxo or hydroxy substituted 5-beta-androstan-17-one to an individual having the syndrome.

REFERENCES:
patent: 4507289 (1985-03-01), Coleman et al.
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4602008 (1986-07-01), Krsek
patent: 4666898 (1987-05-01), Coleman et al.
"Steroid Metabolic Disturbances in Prader-Willi Syndrome"by Fred I. Chasalow et al., American Journal of Medical Genetics, 28:857-864 (1987).
"Prader-Willi Syndrome Scientific Conference III Abstracts", by Bryan D. Hall et al., Clinical Genetics 1989: 35: 299-309.
"Fourth Annual Prader-Willi Syndrome Scientific Conference"Jul. 19, 1989, In Alberta, Canada.

Affiliated with

Also associated with

Rating

Treatment of Prader-Willi syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of Prader-Willi syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Prader-Willi syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2034556